Key result
Therapeutic music may reduce NAFLD steatosis and fibrosis progression via the splenic inflammatory reflex.
Why the study?
Current pharmacological treatments for NAFLD have high cost, adverse side effects, and lack long-term data, creating an urgent clinical need for accessible, safe, and cost-effective interventions.
Does therapeutic music improve neuroimmune-metabolic modulation and reduce systemic inflammation in patients with NAFLD?
Does therapeutic music improve neuroimmune-metabolic modulation and reduce systemic inflammation in patients with NAFLD?
Answers are grounded in this paper and cite their sources.
Therapeutic music is proposed as a mechanistically grounded, non-invasive intervention to modulate the spleen-centered neuroimmune-metabolic axis and potentially attenuate disease progression in NAFLD.
Non-alcoholic fatty liver disease (NAFLD), recently renamed metabolic dysfunction-associated steatotic liver disease, is frequently accompanied by depression and chronic psychological stress that can worsen metabolic dysfunction, promoting NAFLD progression. Given the current limitations of pharmacological treatments for NAFLD, specifically their high cost, potential for adverse side effects, and the lack of long-term data, there is an urgent clinical need for accessible, safe, and cost-effective interventions. Therapeutic music functions as a non-invasive neurocognitive intervention capable of attenuating hypothalamic-pituitary-adrenal axis hyperactivation, restoring parasympathetic tone, and rebalancing immune regulation. These neural and endocrine pathways converge directly on the spleen, a critical immunometabolic nexus translating neuroautonomic signals into systemic inflammatory outputs. Structurally predictable and emotionally engaging acoustic stimuli, such as compositions reminiscent of The Beatles, optimize dopaminergic circuit engagement and alleviate affect-driven inflammatory amplification. This review provides an exploratory, hypothesis-generating delineation of the molecular and physiological networks through which targeted music therapy modulates splenic function. Music therapy emerges not as an ancillary wellness tool, but as a mechanistically grounded intervention at the intersection of neuroimmunology, metabolic medicine, and hepatology, warranting rigorous evaluation in controlled trials.
No takes yet. Share an insight, caveat, or question.
A 2026 study conducted a review in Non-alcoholic fatty liver disease (NAFLD). Therapeutic music was evaluated. Therapeutic music is hypothesized to act as a neuroimmune-metabolic modulator via the splenic inflammatory reflex, potentially reducing hepatic steatosis and fibrosis progression in NAFLD.
Synapse has enriched 10 related papers. Consider them for comparative context: